Syndicate This week's upcoming IPO's and secondary offerings

Week of February 1 to February 5, 2024

This Day's Priced Deals: February 2nd, 2021

Symbol

Issuer

Type

Price

Managers

EYPT

EyePoint
EyePoint
Spot Secondary
Priced: $11.00
9.1M
TD Cowen & Guggenheim

Pricing after close
Deal analysis and details

Managers: TD Cowen & Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IVR

Invesco Mortgage
Invesco Mortgage
Spot Secondary
Priced: $3.83
24M
BofA & JMP Securities

Pricing after close
Deal analysis and details

Managers: BofA & JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

02/01 - Monday

Symbol

Issuer

Type

Price

Managers

YTEN

Yield10 Bioscience
Yield10 Bioscience
Secondary
Priced: $12.25
1.04M
Maxim

Pre-open pricing

Managers: Maxim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EYPT

EyePoint
EyePoint
Spot Secondary
Priced: $11.00
9.1M
TD Cowen & Guggenheim

Pricing after close
Deal analysis and details

Managers: TD Cowen & Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IVR

Invesco Mortgage
Invesco Mortgage
Spot Secondary
Priced: $3.83
24M
BofA & JMP Securities

Pricing after close
Deal analysis and details

Managers: BofA & JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/02 - Tuesday

Symbol

Issuer

Type

Price

Managers

ONTF

On24
On24
IPO
Priced: $50.00
8.561M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, JPMorgan & KeyBanc, Baird, Canaccord, Needham, Piper Sandler, William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TIXT

Telus
Telus
IPO
Priced: $25.00
37M
JPMorgan & Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan & Morgan Stanley, Barclays, BofA, CIBC, Citi, Credit Suisse, RBC Capital, Baird, BMO Capital, Scotiabank, TD Securities, Wells Fargo, William Blair, MUFG, National Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ARGX

Argenx
Argenx
Secondary
Priced: $320.00
1.608M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Morgan Stanley, BofA & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ARQT

Arcutis Biotherapeutics
Arcutis Biotherapeutics
Secondary
Priced: $35.00
5.5M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, TD Cowen, Guggenheim, Truist & Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MBRX

Moleculin Biotech
Moleculin Biotech
Secondary
Priced: $4.75
14.274M
Oppenheimer,...

Pricing after close

Managers: Oppenheimer, Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KRYS

Krystal Biotech
Krystal Biotech
Spot Secondary
Priced: $65.00
1.923M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, TD Cowen & Evercore ISI

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PED

Pedevco
Pedevco
Spot Secondary
Priced: $1.50
5.19M
Kingswood

Pricing after close

Managers: Kingswood

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
X

U.S. Steel
U.S. Steel
Spot Secondary
Priced: $16.65
42M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/03 - Wednesday

Symbol

Issuer

Type

Price

Managers

CNR

Cornerstone Building Brands
Cornerstone Building Brands
Block Trade
Priced: $11.00
4.25M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ATC

Atotech
Atotech
IPO
Priced: $17.00
29.27M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Credit Suisse, BofA & JPMorgan, Barclays, Deutsche Bank, Jefferies, RBC Capital, UBS, Baird, BMO Capital, HSBC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LABP

Landos Biopharma
Landos Biopharma
IPO
Priced: $16.00
6.25M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Jefferies & Leerink, Raymond James

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SANA

Sana Biotechnology
Sana Biotechnology
IPO
Priced: $25.00
23.5M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley, Goldman Sachs, JPMorgan & BofA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SNSE

Sensei Biotherapeutics
Sensei Biotherapeutics
IPO
Priced: $19.00
7M
Citi,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Citi, Piper Sandler & Berenberg, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ALB

Albemarle
Albemarle
Secondary
Priced: $153.00
8.5M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, BofA, HSBC, MIZU, MUFG, SMBC Nikko

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CURI

CuriosityStream
CuriosityStream
Secondary
Priced: $13.50
6.5M
BofA,...

Pricing after close

Managers: BofA, Needham, DA Davidson, Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NSPR

InspireMD
InspireMD
Secondary
Priced: $.62
29.033M
Alliance Global Partners

Pricing after close

Managers: Alliance Global Partners

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RVMD

Revolution Medicines
Revolution Medicines
Secondary
Priced: $45.00
5.8M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, TD Cowen, Leerink & Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AQB

AquaBounty
AquaBounty
Spot Secondary
Priced: $8.50
13M
Oppenheimer & Lake Street

Pricing after close

Managers: Oppenheimer & Lake Street

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AWH

Aspira Women's Health
Aspira Women's Health
Spot Secondary
Priced: $7.50
6M
William Blair & Truist,...

Pricing after close
Deal analysis and details

Managers: William Blair & Truist, Brookline

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BTN

Ballantyne Strong
Ballantyne Strong
Spot Secondary
Priced: $2.30
3.29M
ThinkEquity

Pricing after close

Managers: ThinkEquity

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DRRX

Durect
Durect
Spot Secondary
Priced: $2.38
17.708M
Cantor Fitzgerald

Pricing after close
Deal analysis and details

Managers: Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HYRE

HyreCar
HyreCar
Spot Secondary
Priced: $11.75
2.2M
Lake Street & Northland

Pricing after close

Managers: Lake Street & Northland

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IEA

Infrastructure and Energy Alternatives
Infrastructure and Energy Alternatives
Spot Secondary
Priced: $16.75
8M
Guggenheim,...

Pricing after close
Deal analysis and details

Managers: Guggenheim, Stifel, DA Davidson

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ISR

IsoRay
IsoRay
Spot Secondary
Priced: $1.25
36M
Oppenheimer

Pricing after close
Deal analysis and details

Managers: Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KLDO

Kaleido Biosciences
Kaleido Biosciences
Spot Secondary
Priced: $11.50
5.25M
Morgan Stanley & Piper Sandler

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & Piper Sandler

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
QMCO

Quantum
Quantum
Spot Secondary
Priced: $6.85
13.14M
B. Riley & Oppenheimer,...

Pricing after close

Managers: B. Riley & Oppenheimer, LAKE, Craig-Hallum, Northland

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
QTRX

Quanterix
Quanterix
Spot Secondary
Priced: $70.00
3.6M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Leerink & TD Cowen, Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/04 - Thursday

Symbol

Issuer

Type

Price

Managers

ANGN

Angion Biomedica
Angion Biomedica
IPO
Priced: $16.00
5M
TD Cowen & Stifel,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: TD Cowen & Stifel, H.C. Wainwright, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BOLT

Bolt Biotherapeutics
Bolt Biotherapeutics
IPO
Priced: $20.00
11.5M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley, Leerink, Stifel & Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CNEY

CN Energy
CN Energy
IPO
Priced: $4.00
5M
Network 1 Financial

Pricing after close

Managers: Network 1 Financial

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EVAX

Evaxion Biotech
Evaxion Biotech
IPO
Priced: $10.00
3M
Oppenheimer,...

Pricing after close
Deal analysis and details

Managers: Oppenheimer, Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IMCR

Immunocore
Immunocore
IPO
Priced: $26.00
9.936M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, JPMorgan & Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LHDX

Lucira Health
Lucira Health
IPO
Priced: $17.00
9M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, William Blair & LifeSci Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PHVS

Pharvaris
Pharvaris
IPO
Priced: $20.00
8.27M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley, BofA & Leerink, Oppenheimer, Kempen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TERN

Terns Pharmaceuticals
Terns Pharmaceuticals
IPO
Priced: $17.00
7.5M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Goldman Sachs & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VOR

Vor Biopharma
Vor Biopharma
IPO
Priced: $18.00
9.83M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, Evercore ISI, Barclays & Stifel

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ALGM

Allegro MicroSystems
Allegro MicroSystems
Secondary
Priced: $30.30
17.5M
Barclays,...

Pricing after close
Deal analysis and details

Managers: Barclays, Credit Suisse & Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DSS

Document Security
Document Security
Secondary
Priced: $2.80
12.3M
Aegis

Pricing after close

Managers: Aegis

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
JHG

Janus Henderson Group
Janus Henderson Group
Secondary
Priced: $29.25
30.7M
Goldman Sachs

Pricing after close

Managers: Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NOG

Northern Oil and Gas
Northern Oil and Gas
Secondary
Priced: $9.75
12.5M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, RBC Capital, Wells Fargo & Citi

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OPEN

Opendoor Technologies
Opendoor Technologies
Secondary
Priced: $27.00
28M
Citi & Goldman Sachs

Pricing after close
Deal analysis and details

Managers: Citi & Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RYTM

Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Secondary
Priced: $30.00
5M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, BofA, TD Cowen & Stifel, Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VCYT

Veracyte
Veracyte
Secondary
Priced: $74.00
7.432M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Leerink & William Blair, BTIG, Needham, Lake Street

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ITMR

Itamar Medical
Itamar Medical
Spot Secondary
Priced: $22.75
3M
Piper Sandler,...

Pricing after close
Deal analysis and details

Managers: Piper Sandler, TD Cowen & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OCX

OncoCyte
OncoCyte
Spot Secondary
Priced: $4.50
7.78M
Piper Sandler,...

Pricing after close
Deal analysis and details

Managers: Piper Sandler, BTIG, Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SBNY

Signature Bank
Signature Bank
Spot Secondary
Priced: $178.00
3.5M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Morgan Stanley & Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/05 - Friday

Symbol

Issuer

Type

Price

Managers

REKR

Rekor Systems
Rekor Systems
Spot Secondary
Priced: $12.25
5.33M
B. Riley & Lake Street

Pre-open pricing

Managers: B. Riley & Lake Street

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access